>_ QFI Terminal
Terminal › Stocks › CMND

Clearmind Medicine Inc. (CMND) Stock

Healthcare · Biotechnology · CA
$1.16 -31.76%
Last updated Sep 20, 2026 15:00 UTC

CMND Key Statistics

Market Cap$158,524.44
P/E (TTM)-0.04
P/S (TTM)—
P/B (TTM)0.16
Revenue (TTM)$0.00
EPS (TTM)$-32.14
Dividend Yield—
ROE (TTM)-211.90%
Net Margin0.00%
Gross Margin0.00%
52W High$15.20
52W Low$0.59
Analyst View—
Price Target—
Employees4
Volume15,512,447

About Clearmind Medicine Inc.

Clearmind Medicine Inc., a pre-clinical pharmaceutical company, develops novel psychedelic medicines to treat under-served health problems. It develops treatments for alcohol use disorders, including binge drinking and eating disorders, as well as depression, binge eating, psychotherapy, mental health issues, and other binge behaviors. The company was formerly known as Cyntar Ventures Inc. and changed its name to Clearmind Medicine Inc. in March 2021. Clearmind Medicine Inc. was incorporated in 2017 and is based in Vancouver, Canada.

CEO: Adi Zuloff-Shani. Company website

CMND — Frequently Asked Questions

What is the CMND stock price today?

Clearmind Medicine Inc. (CMND) trades at $1.16, down 31.76% on the day, as of Sep 20, 2026 15:00 UTC.

What is Clearmind Medicine Inc.'s market cap?

Clearmind Medicine Inc. has a market capitalisation of $158,524.44, calculated from the live CMND share price and shares outstanding.

What is the P/E ratio of CMND?

CMND has no meaningful price-to-earnings ratio: Clearmind Medicine Inc. lost $32.14 per share over the last twelve months, and a P/E is only defined on positive earnings.

How much revenue does Clearmind Medicine Inc. make?

Clearmind Medicine Inc. generated revenue of $0.00 over the trailing twelve months.

What is the 52-week range for CMND?

CMND has traded between $0.59 and $15.20 over the past 52 weeks, and the last price is 92.4% below that high.

Is Clearmind Medicine Inc. profitable?

Yes. Clearmind Medicine Inc. keeps 0.00% of revenue as net income over the trailing twelve months.

What sector is Clearmind Medicine Inc. in?

Clearmind Medicine Inc. is classified under the Healthcare sector and the Biotechnology industry, and is domiciled in CA .

Who is the CEO of Clearmind Medicine Inc.?

Adi Zuloff-Shani is the chief executive of Clearmind Medicine Inc., which employs 4 people.

Where can I track CMND in real time?

QFI Terminal shows CMND with live charts, full financials, the options chain with gamma exposure, institutional ownership and analyst ratings on one screen. The free plan has no time limit and asks for no card.

See CMND live in QFI Terminal

Interactive charts, full financials, options chain, gamma exposure, ownership and analyst ratings, all in one institutional-grade terminal.

Open CMND in Terminal See plans

Biotechnology stocks

REGN Regeneron Pharmaceuticals, Inc. VRTX Vertex Pharmaceuticals Incorporated ONC BeOne Medicines AG ARGX argenx SE INCY Incyte Corporation ALNY Alnylam Pharmaceuticals, Inc. JAZZ Jazz Pharmaceuticals plc GMAB Genmab A/S

More Healthcare stocks

UNH UnitedHealth Group Incorporated CVS CVS Health Corp. MCK McKesson Corporation COR Cencora, Inc. NVO Novo Nordisk A/S CI Cigna Corporation CAH Cardinal Health, Inc. ELV Elevance Health Inc.